Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion type Assertion NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_head.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion description "[NY-ESO-1-specific IgG antibodies were detected in the sera of 10% of neuroblastoma patients with stage III or IV disease, but not in patients in clinical remission or with earlier stages.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_provenance.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion evidence source_evidence_literature NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_provenance.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion SIO_000772 14583496 NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_provenance.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion wasDerivedFrom befree-20140225 NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_provenance.
- NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_assertion wasGeneratedBy ECO_0000203 NP559165.RATiCBW2QxXxsT6nMlwIbxKfV-dxMilKwZwAinDA5I2-Q130_provenance.